Gail bladder motor function is impaired in some patients with diabetes. It has been suggested that the abnormalities of gall bladder motility are confined to those patients with autonomic neuropathy. Erythromycin, a motilin receptor agonist, causes gail bladder contraction in both normal subjects and patients with gail stones with impaired gall bladder emptying. The effect of erythromycin on gail bladder motility in seven patients with diabetes with an autonomic neuropathy, six patients with diabetes without autonomic neuropathy,. and 17 normal subjects was studied using ultrasound. There was no significant difference in gail bladder fasting volume between the three groups, but the patients with diabetes with autonomic neuropathy had impaired postprandial gail bladder emptying compared with normal subjects (percentage emptied (SEM) 40 (10-3)% v 64 (2.8)%, p<001) and those with autonomic neuropathy (48 (7.7)%, NS). Erythromycin produced a dramatic reduction in gail bladder fasting volume in patients with diabetes with an autonomic neuropathy, compared with either normal subjects or patients with diabetes without autonomic neuropathy (percentage reduction 62 (4.6)% in patients with autonomic neuropathy, v 37 (17.6)% in those without autonomic neuropathy, and 26 (7.3)% in the normal subjects, (p<002) and returned gall bladder emptying to normal in all patients with impaired emptying. The pronounced effect of erythromycin in diabetic autonomic neuropathy suggests denervation supersensitivity and that the action of erythromycin on the gall bladder is neurally modulated.
Abstract
Gail bladder motor function is impaired in some patients with diabetes. It has been suggested that the abnormalities of gall bladder motility are confined to those patients with autonomic neuropathy. Erythromycin, a motilin receptor agonist, causes gail bladder contraction in both normal subjects and patients with gail stones with impaired gall bladder emptying. The effect of erythromycin on gail bladder motility in seven patients with diabetes with an autonomic neuropathy, six patients with diabetes without autonomic neuropathy,. and 17 normal subjects was studied using ultrasound. There was no significant difference in gail bladder fasting volume between the three groups, but the patients with diabetes with autonomic neuropathy had impaired postprandial gail bladder emptying compared with normal subjects (percentage emptied (SEM) 40 (10-3)% v 64 (2.8)%, p<001) and those with autonomic neuropathy (48 (7.7)%, NS). Erythromycin produced a dramatic reduction in gail bladder fasting volume in patients with diabetes with an autonomic neuropathy, compared with either normal subjects or patients with diabetes without autonomic neuropathy (percentage reduction 62 (4.6)% in patients with autonomic neuropathy, v 37 (17.6)% in those without autonomic neuropathy, and 26 (7. 3)% in the normal subjects, (p<002) and returned gall bladder emptying to normal in all patients with impaired emptying. The pronounced effect of erythromycin in diabetic autonomic neuropathy suggests denervation supersensitivity and that the action of erythromycin on the gall bladder is neurally modulated. (Gut 1993; 34: 1123 -1127 Erythromycin, and some of its analogues, are potent motilin receptor agonists and will stimulate gastrointestinal motor activity in many species, including man.' It has been suggested, however, that not all of the effect of erythromycin on gastrointestinal motility is mediated by the motilin receptor as some of the actions of erythromycin are dissimilar to those ofexogenous motilin.' Erythromycin will change the cycle length of the migrating motor complex in progress and, at high doses cause giant retrograde antral contractions and clustered contractions in the duodenum. None of these phenomena have been described with motilin. We have shown that oral erythromycin will provoke gall bladder contraction in man, in both normal subjects and those with gall stone disease, although the exact mechanism is unclear.3 There is, however, some preliminary evidence that cholinergic mechanisms play a part in the action of erythromycin on the small intestine and the gall bladder. 45 Gall bladder motor function abnormalities have been described in patients with diabetes. Gitelson et a16 were the first to report that diabetic patients have larger gall bladders than normal and this has also been confirmed by other groups.7 In addition it has been reported that postprandial gall bladder contraction is impaired, and that these abnormalities are confined to those patients with autonomic neuropathy.8 10 We have investigated the effect of oral erythromycin on gall bladder fasting volume and postprandial gall bladder emptying in diabetic patients with and without an autonomic neuropathy and compared this with the action of erythromycin on gall bladder motility in normal subjects.
Methods

SUBJECTS
Diabetic patients were recruited from the Department of Diabetic Medicine, King's College Hospital, London. None had any history or symptoms of gall stone disease and none were taking any drugs apart from insulin or oral hypoglycaemic agents. Two groups of diabetic patients were studied. GROUP A Seven diabetic patients with autonomic neuropathy. Their median age was 52 years (range 48-69), four of whom were women. The presence of autonomic neuropathy was defined according to the following criteria": (i) heart rate variability on six maximal respiratory efforts of less than 10 beats per minute; (ii) abnormal heart rate response to the Valsalva manouvre (that is, a ratio ofless than 1:1.15; (iii) heart rate increase of less than 10 Although there was a trend for increased fasting gall bladder volume in the diabetic groups compared with normal subjects, this did not reach significance (Fig 1) . Diabetic patients with autonomic neuropathy had impaired gall bladder emptying after the test meal, compared with normal controls (mean maximal percentage emptied 40 (10-3)% v 64 (2-8)%, p<0-01), but there was no significant difference between normal subjects and diabetic patients without autonomic neuropathy (maximal percentage emptied 64 (2 8)% v 48 (7 6)% respectively). Within both diabetic groups, however, there were some patients with impaired postprandial gall bladder emptying (>2 SD from the mean of the normal controls) (Fig 2) .
Reduced gall bladder emptying in those with autonomic neuropathy was reflected in a trend towards increased mean postprandial residual gall bladder volume (20-7 (7-7) ml), compared with diabetic patients without autonomic neuropathy (15-6 (3-6) ml) and normal subjects (9-0 (0-9) ml), although this failed to reach significance.
The rate constant of postprandial emptying 
Discussion
We have found that fasting gall bladder volume was similar in both groups of diabetic patients but the diabetic patients with autonomic neuropathy had impaired gall bladder emptying after the meal compared with those without autonomic neuropathy, at least after the liquid meal stimulus used in these studies. This may be consequent upon delayed gastric emptying due to diabetic gastroparesis changing nutrient delivery to the duodenum and therefore release of cholecystokinin, although the time course of gall bladder emptying was normal. If gastric stasis was responsible for the poor gall bladder emptying, one might expect that gall bladder contraction after the meal would be delayed. Other workers have also described impaired gall bladder emptying in response to a meal stimulus in diabetic patients and most data would suggest that this emptying defect is confined to those with autonomic neuropathy.1'0 There is evidence of cholinergic nerve damage in these patients, as the cephalic phase of gall bladder emptying that is mediated by cholinergic pathways has been shown to be abnormal in these patients. '5 Lithogenic bile with cholesterol supersaturation is a prerequisite for cholesterol gall stone formation. Many normal subjects without gall stones, however, also have supersaturated bile and other factors must be therefore involved. 16 In conclusion, we have confirmed previous work that has shown that postprandial gall bladder emptying is impaired in diabetic patients with autonomic neuropathy. In addition, we have also shown that erythromycin causes pronounced contraction of the gall bladder in the fasting state in those patients with neuropathy compared with those without, perhaps suggesting that the action of erythromycin on the gall bladder may be mediated by neural pathways.
The potential role of erythromycin as a gall bladder prokinetic agent has yet to be explored, but in patients at known high risk of gall bladder sludge and stone formation, such as those on parenteral nutrition, erythromycin may have a role in prophylaxis.
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